1 Study Coverage
    1.1 Oncology Based Molecular Diagnostics Product Introduction
    1.2 Market by Type
        1.2.1 Global Oncology Based Molecular Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 PCR
        1.2.3 Multiplex PCR
        1.2.4 In Situ Hybridization
        1.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
    1.3 Market by Application
        1.3.1 Global Oncology Based Molecular Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Breast Cancer
        1.3.3 Prostate Cancer
        1.3.4 Colorectal Cancer
        1.3.5 Cervical Cancer
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Oncology Based Molecular Diagnostics Sales Estimates and Forecasts 2017-2028
    2.2 Global Oncology Based Molecular Diagnostics Revenue Estimates and Forecasts 2017-2028
    2.3 Global Oncology Based Molecular Diagnostics Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Oncology Based Molecular Diagnostics Sales by Region
        2.4.1 Global Oncology Based Molecular Diagnostics Sales by Region (2017-2022)
        2.4.2 Global Sales Oncology Based Molecular Diagnostics by Region (2023-2028)
    2.5 Global Oncology Based Molecular Diagnostics Revenue by Region
        2.5.1 Global Oncology Based Molecular Diagnostics Revenue by Region (2017-2022)
        2.5.2 Global Oncology Based Molecular Diagnostics Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Oncology Based Molecular Diagnostics Sales by Manufacturers
        3.1.1 Global Top Oncology Based Molecular Diagnostics Manufacturers by Sales (2017-2022)
        3.1.2 Global Oncology Based Molecular Diagnostics Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oncology Based Molecular Diagnostics in 2021
    3.2 Global Oncology Based Molecular Diagnostics Revenue by Manufacturers
        3.2.1 Global Oncology Based Molecular Diagnostics Revenue by Manufacturers (2017-2022)
        3.2.2 Global Oncology Based Molecular Diagnostics Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Oncology Based Molecular Diagnostics Revenue in 2021
    3.3 Global Oncology Based Molecular Diagnostics Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Oncology Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Oncology Based Molecular Diagnostics Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Oncology Based Molecular Diagnostics Sales by Type
        4.1.1 Global Oncology Based Molecular Diagnostics Historical Sales by Type (2017-2022)
        4.1.2 Global Oncology Based Molecular Diagnostics Forecasted Sales by Type (2023-2028)
        4.1.3 Global Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
    4.2 Global Oncology Based Molecular Diagnostics Revenue by Type
        4.2.1 Global Oncology Based Molecular Diagnostics Historical Revenue by Type (2017-2022)
        4.2.2 Global Oncology Based Molecular Diagnostics Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Oncology Based Molecular Diagnostics Revenue Market Share by Type (2017-2028)
    4.3 Global Oncology Based Molecular Diagnostics Price by Type
        4.3.1 Global Oncology Based Molecular Diagnostics Price by Type (2017-2022)
        4.3.2 Global Oncology Based Molecular Diagnostics Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Oncology Based Molecular Diagnostics Sales by Application
        5.1.1 Global Oncology Based Molecular Diagnostics Historical Sales by Application (2017-2022)
        5.1.2 Global Oncology Based Molecular Diagnostics Forecasted Sales by Application (2023-2028)
        5.1.3 Global Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
    5.2 Global Oncology Based Molecular Diagnostics Revenue by Application
        5.2.1 Global Oncology Based Molecular Diagnostics Historical Revenue by Application (2017-2022)
        5.2.2 Global Oncology Based Molecular Diagnostics Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Oncology Based Molecular Diagnostics Revenue Market Share by Application (2017-2028)
    5.3 Global Oncology Based Molecular Diagnostics Price by Application
        5.3.1 Global Oncology Based Molecular Diagnostics Price by Application (2017-2022)
        5.3.2 Global Oncology Based Molecular Diagnostics Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Oncology Based Molecular Diagnostics Market Size by Type
        6.1.1 North America Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
        6.1.2 North America Oncology Based Molecular Diagnostics Revenue by Type (2017-2028)
    6.2 North America Oncology Based Molecular Diagnostics Market Size by Application
        6.2.1 North America Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
        6.2.2 North America Oncology Based Molecular Diagnostics Revenue by Application (2017-2028)
    6.3 North America Oncology Based Molecular Diagnostics Market Size by Country
        6.3.1 North America Oncology Based Molecular Diagnostics Sales by Country (2017-2028)
        6.3.2 North America Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Oncology Based Molecular Diagnostics Market Size by Type
        7.1.1 Europe Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
        7.1.2 Europe Oncology Based Molecular Diagnostics Revenue by Type (2017-2028)
    7.2 Europe Oncology Based Molecular Diagnostics Market Size by Application
        7.2.1 Europe Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
        7.2.2 Europe Oncology Based Molecular Diagnostics Revenue by Application (2017-2028)
    7.3 Europe Oncology Based Molecular Diagnostics Market Size by Country
        7.3.1 Europe Oncology Based Molecular Diagnostics Sales by Country (2017-2028)
        7.3.2 Europe Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Oncology Based Molecular Diagnostics Market Size by Type
        8.1.1 Asia Pacific Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
        8.1.2 Asia Pacific Oncology Based Molecular Diagnostics Revenue by Type (2017-2028)
    8.2 Asia Pacific Oncology Based Molecular Diagnostics Market Size by Application
        8.2.1 Asia Pacific Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
        8.2.2 Asia Pacific Oncology Based Molecular Diagnostics Revenue by Application (2017-2028)
    8.3 Asia Pacific Oncology Based Molecular Diagnostics Market Size by Region
        8.3.1 Asia Pacific Oncology Based Molecular Diagnostics Sales by Region (2017-2028)
        8.3.2 Asia Pacific Oncology Based Molecular Diagnostics Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Oncology Based Molecular Diagnostics Market Size by Type
        9.1.1 Latin America Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
        9.1.2 Latin America Oncology Based Molecular Diagnostics Revenue by Type (2017-2028)
    9.2 Latin America Oncology Based Molecular Diagnostics Market Size by Application
        9.2.1 Latin America Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
        9.2.2 Latin America Oncology Based Molecular Diagnostics Revenue by Application (2017-2028)
    9.3 Latin America Oncology Based Molecular Diagnostics Market Size by Country
        9.3.1 Latin America Oncology Based Molecular Diagnostics Sales by Country (2017-2028)
        9.3.2 Latin America Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Oncology Based Molecular Diagnostics Market Size by Type
        10.1.1 Middle East and Africa Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Type (2017-2028)
    10.2 Middle East and Africa Oncology Based Molecular Diagnostics Market Size by Application
        10.2.1 Middle East and Africa Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Application (2017-2028)
    10.3 Middle East and Africa Oncology Based Molecular Diagnostics Market Size by Country
        10.3.1 Middle East and Africa Oncology Based Molecular Diagnostics Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Corporation Information
        11.1.2 Abbott Laboratories Overview
        11.1.3 Abbott Laboratories Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Abbott Laboratories Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Abbott Laboratories Recent Developments
    11.2 Bayer Healthcare
        11.2.1 Bayer Healthcare Corporation Information
        11.2.2 Bayer Healthcare Overview
        11.2.3 Bayer Healthcare Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bayer Healthcare Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bayer Healthcare Recent Developments
    11.3 Becton Dickinson
        11.3.1 Becton Dickinson Corporation Information
        11.3.2 Becton Dickinson Overview
        11.3.3 Becton Dickinson Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Becton Dickinson Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Becton Dickinson Recent Developments
    11.4 Cepheid
        11.4.1 Cepheid Corporation Information
        11.4.2 Cepheid Overview
        11.4.3 Cepheid Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Cepheid Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Cepheid Recent Developments
    11.5 Dako
        11.5.1 Dako Corporation Information
        11.5.2 Dako Overview
        11.5.3 Dako Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Dako Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Dako Recent Developments
    11.6 Danaher Corporation
        11.6.1 Danaher Corporation Corporation Information
        11.6.2 Danaher Corporation Overview
        11.6.3 Danaher Corporation Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Danaher Corporation Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Danaher Corporation Recent Developments
    11.7 Gen Probe(Hologic)
        11.7.1 Gen Probe(Hologic) Corporation Information
        11.7.2 Gen Probe(Hologic) Overview
        11.7.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Gen Probe(Hologic) Recent Developments
    11.8 Roche Diagnostics
        11.8.1 Roche Diagnostics Corporation Information
        11.8.2 Roche Diagnostics Overview
        11.8.3 Roche Diagnostics Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Roche Diagnostics Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Roche Diagnostics Recent Developments
    11.9 Siemens Healthcare
        11.9.1 Siemens Healthcare Corporation Information
        11.9.2 Siemens Healthcare Overview
        11.9.3 Siemens Healthcare Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Siemens Healthcare Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Siemens Healthcare Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Oncology Based Molecular Diagnostics Industry Chain Analysis
    12.2 Oncology Based Molecular Diagnostics Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Oncology Based Molecular Diagnostics Production Mode & Process
    12.4 Oncology Based Molecular Diagnostics Sales and Marketing
        12.4.1 Oncology Based Molecular Diagnostics Sales Channels
        12.4.2 Oncology Based Molecular Diagnostics Distributors
    12.5 Oncology Based Molecular Diagnostics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Oncology Based Molecular Diagnostics Industry Trends
    13.2 Oncology Based Molecular Diagnostics Market Drivers
    13.3 Oncology Based Molecular Diagnostics Market Challenges
    13.4 Oncology Based Molecular Diagnostics Market Restraints
14 Key Findings in The Global Oncology Based Molecular Diagnostics Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Oncology Based Molecular Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of PCR
    Table 3. Major Manufacturers of Multiplex PCR
    Table 4. Major Manufacturers of In Situ Hybridization
    Table 5. Major Manufacturers of Isothermal Nucleic Acid Amplification Technology (INAAT)
    Table 6. Global Oncology Based Molecular Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Oncology Based Molecular Diagnostics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Oncology Based Molecular Diagnostics Sales by Region (2017-2022) & (K Units)
    Table 9. Global Oncology Based Molecular Diagnostics Sales Market Share by Region (2017-2022)
    Table 10. Global Oncology Based Molecular Diagnostics Sales by Region (2023-2028) & (K Units)
    Table 11. Global Oncology Based Molecular Diagnostics Sales Market Share by Region (2023-2028)
    Table 12. Global Oncology Based Molecular Diagnostics Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Oncology Based Molecular Diagnostics Revenue Market Share by Region (2017-2022)
    Table 14. Global Oncology Based Molecular Diagnostics Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Oncology Based Molecular Diagnostics Revenue Market Share by Region (2023-2028)
    Table 16. Global Oncology Based Molecular Diagnostics Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Oncology Based Molecular Diagnostics Sales Share by Manufacturers (2017-2022)
    Table 18. Global Oncology Based Molecular Diagnostics Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Oncology Based Molecular Diagnostics Revenue Share by Manufacturers (2017-2022)
    Table 20. Oncology Based Molecular Diagnostics Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Oncology Based Molecular Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Oncology Based Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Molecular Diagnostics as of 2021)
    Table 23. Oncology Based Molecular Diagnostics Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Oncology Based Molecular Diagnostics Product Offered
    Table 25. Date of Manufacturers Enter into Oncology Based Molecular Diagnostics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
    Table 28. Global Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
    Table 29. Global Oncology Based Molecular Diagnostics Sales Share by Type (2017-2022)
    Table 30. Global Oncology Based Molecular Diagnostics Sales Share by Type (2023-2028)
    Table 31. Global Oncology Based Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Oncology Based Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Oncology Based Molecular Diagnostics Revenue Share by Type (2017-2022)
    Table 34. Global Oncology Based Molecular Diagnostics Revenue Share by Type (2023-2028)
    Table 35. Oncology Based Molecular Diagnostics Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Oncology Based Molecular Diagnostics Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
    Table 38. Global Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
    Table 39. Global Oncology Based Molecular Diagnostics Sales Share by Application (2017-2022)
    Table 40. Global Oncology Based Molecular Diagnostics Sales Share by Application (2023-2028)
    Table 41. Global Oncology Based Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Oncology Based Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Oncology Based Molecular Diagnostics Revenue Share by Application (2017-2022)
    Table 44. Global Oncology Based Molecular Diagnostics Revenue Share by Application (2023-2028)
    Table 45. Oncology Based Molecular Diagnostics Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Oncology Based Molecular Diagnostics Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
    Table 48. North America Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
    Table 49. North America Oncology Based Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Oncology Based Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
    Table 52. North America Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
    Table 53. North America Oncology Based Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Oncology Based Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Oncology Based Molecular Diagnostics Sales by Country (2017-2022) & (K Units)
    Table 56. North America Oncology Based Molecular Diagnostics Sales by Country (2023-2028) & (K Units)
    Table 57. North America Oncology Based Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Oncology Based Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Oncology Based Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Oncology Based Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Oncology Based Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Oncology Based Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Oncology Based Molecular Diagnostics Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Oncology Based Molecular Diagnostics Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Oncology Based Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Oncology Based Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Oncology Based Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Oncology Based Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Oncology Based Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Oncology Based Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Oncology Based Molecular Diagnostics Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Oncology Based Molecular Diagnostics Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Oncology Based Molecular Diagnostics Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Oncology Based Molecular Diagnostics Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Oncology Based Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Oncology Based Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Oncology Based Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Oncology Based Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Oncology Based Molecular Diagnostics Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Oncology Based Molecular Diagnostics Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Oncology Based Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Oncology Based Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Oncology Based Molecular Diagnostics Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Oncology Based Molecular Diagnostics Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Oncology Based Molecular Diagnostics Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Oncology Based Molecular Diagnostics Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Oncology Based Molecular Diagnostics Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Oncology Based Molecular Diagnostics Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Abbott Laboratories Corporation Information
    Table 108. Abbott Laboratories Description and Major Businesses
    Table 109. Abbott Laboratories Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Abbott Laboratories Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Abbott Laboratories Recent Developments
    Table 112. Bayer Healthcare Corporation Information
    Table 113. Bayer Healthcare Description and Major Businesses
    Table 114. Bayer Healthcare Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Bayer Healthcare Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Bayer Healthcare Recent Developments
    Table 117. Becton Dickinson Corporation Information
    Table 118. Becton Dickinson Description and Major Businesses
    Table 119. Becton Dickinson Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Becton Dickinson Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Becton Dickinson Recent Developments
    Table 122. Cepheid Corporation Information
    Table 123. Cepheid Description and Major Businesses
    Table 124. Cepheid Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Cepheid Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Cepheid Recent Developments
    Table 127. Dako Corporation Information
    Table 128. Dako Description and Major Businesses
    Table 129. Dako Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Dako Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Dako Recent Developments
    Table 132. Danaher Corporation Corporation Information
    Table 133. Danaher Corporation Description and Major Businesses
    Table 134. Danaher Corporation Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Danaher Corporation Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Danaher Corporation Recent Developments
    Table 137. Gen Probe(Hologic) Corporation Information
    Table 138. Gen Probe(Hologic) Description and Major Businesses
    Table 139. Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Gen Probe(Hologic) Recent Developments
    Table 142. Roche Diagnostics Corporation Information
    Table 143. Roche Diagnostics Description and Major Businesses
    Table 144. Roche Diagnostics Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. Roche Diagnostics Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Roche Diagnostics Recent Developments
    Table 147. Siemens Healthcare Corporation Information
    Table 148. Siemens Healthcare Description and Major Businesses
    Table 149. Siemens Healthcare Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. Siemens Healthcare Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Siemens Healthcare Recent Developments
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Oncology Based Molecular Diagnostics Distributors List
    Table 155. Oncology Based Molecular Diagnostics Customers List
    Table 156. Oncology Based Molecular Diagnostics Market Trends
    Table 157. Oncology Based Molecular Diagnostics Market Drivers
    Table 158. Oncology Based Molecular Diagnostics Market Challenges
    Table 159. Oncology Based Molecular Diagnostics Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oncology Based Molecular Diagnostics Product Picture
    Figure 3. Global Oncology Based Molecular Diagnostics Market Share by Type in 2021 & 2028
    Figure 3. PCR Product Picture
    Figure 4. Multiplex PCR Product Picture
    Figure 5. In Situ Hybridization Product Picture
    Figure 6. Isothermal Nucleic Acid Amplification Technology (INAAT) Product Picture
    Figure 7. Global Oncology Based Molecular Diagnostics Market Share by Application in 2021 & 2028
    Figure 8. Breast Cancer
    Figure 9. Prostate Cancer
    Figure 10. Colorectal Cancer
    Figure 11. Cervical Cancer
    Figure 12. Other
    Figure 13. Oncology Based Molecular Diagnostics Report Years Considered
    Figure 14. Global Oncology Based Molecular Diagnostics Sales 2017-2028 (K Units)
    Figure 15. Global Oncology Based Molecular Diagnostics Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Oncology Based Molecular Diagnostics Revenue 2017-2028 (US$ Million)
    Figure 17. Global Oncology Based Molecular Diagnostics Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Oncology Based Molecular Diagnostics Sales Market Share by Region (2017-2022)
    Figure 19. Global Oncology Based Molecular Diagnostics Sales Market Share by Region (2023-2028)
    Figure 20. North America Oncology Based Molecular Diagnostics Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Oncology Based Molecular Diagnostics Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Oncology Based Molecular Diagnostics Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Oncology Based Molecular Diagnostics Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Oncology Based Molecular Diagnostics Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Oncology Based Molecular Diagnostics Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Oncology Based Molecular Diagnostics Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Oncology Based Molecular Diagnostics Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Oncology Based Molecular Diagnostics Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Oncology Based Molecular Diagnostics Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Oncology Based Molecular Diagnostics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Oncology Based Molecular Diagnostics in the World: Market Share by Oncology Based Molecular Diagnostics Revenue in 2021
    Figure 32. Global Oncology Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
    Figure 34. Global Oncology Based Molecular Diagnostics Revenue Market Share by Type (2017-2028)
    Figure 35. Global Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
    Figure 36. Global Oncology Based Molecular Diagnostics Revenue Market Share by Application (2017-2028)
    Figure 37. North America Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
    Figure 38. North America Oncology Based Molecular Diagnostics Revenue Market Share by Type (2017-2028)
    Figure 39. North America Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
    Figure 40. North America Oncology Based Molecular Diagnostics Revenue Market Share by Application (2017-2028)
    Figure 41. North America Oncology Based Molecular Diagnostics Sales Share by Country (2017-2028)
    Figure 42. North America Oncology Based Molecular Diagnostics Revenue Share by Country (2017-2028)
    Figure 43. U.S. Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
    Figure 46. Europe Oncology Based Molecular Diagnostics Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
    Figure 48. Europe Oncology Based Molecular Diagnostics Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Oncology Based Molecular Diagnostics Sales Share by Country (2017-2028)
    Figure 50. Europe Oncology Based Molecular Diagnostics Revenue Share by Country (2017-2028)
    Figure 51. Germany Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 52. France Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Oncology Based Molecular Diagnostics Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Oncology Based Molecular Diagnostics Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Oncology Based Molecular Diagnostics Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Oncology Based Molecular Diagnostics Revenue Share by Region (2017-2028)
    Figure 62. China Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 65. India Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Oncology Based Molecular Diagnostics Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Oncology Based Molecular Diagnostics Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Oncology Based Molecular Diagnostics Sales Share by Country (2017-2028)
    Figure 77. Latin America Oncology Based Molecular Diagnostics Revenue Share by Country (2017-2028)
    Figure 78. Mexico Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Oncology Based Molecular Diagnostics Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Oncology Based Molecular Diagnostics Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Oncology Based Molecular Diagnostics Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Oncology Based Molecular Diagnostics Revenue Share by Country (2017-2028)
    Figure 87. Turkey Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Oncology Based Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 90. Oncology Based Molecular Diagnostics Value Chain
    Figure 91. Oncology Based Molecular Diagnostics Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed